Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15296993 | 1.00 | SF3B3 (0.50) | SF3B3HMGCR | |
| SCHEMBL16705979 | 1.00 | SF3B3 (0.50) | SF3B3HMGCR | |
| SCHEMBL15296992 | 1.00 | SF3B3 (0.50) | SF3B3HMGCR | |
| SCHEMBL16705940 | 0.91 | SF3B3 (0.46) | SF3B3 | |
| SCHEMBL16705950 | 0.91 | SF3B3 (0.46) | SF3B3 | |
| SCHEMBL16705945 | 0.91 | SF3B3 (0.46) | SF3B3 | |
| SCHEMBL16705967 | 0.91 | SF3B3 (0.46) | SF3B3 | |
| SCHEMBL3550393 | 0.91 | SF3B3 (0.55) | SF3B3 | |
| SCHEMBL12298672 | 0.91 | SF3B3 (0.55) | SF3B3 | |
| SCHEMBL15297008 | 0.91 | SF3B3 (0.55) | SF3B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9604973-B2 | Anti-cancer polyketide compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-03-28 | — | — | US | disclosed |
| US-9604973-B2 | Anti-cancer polyketide compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-03-28 | — | — | US | disclosed |
| US-20150133535-A1 | ANTI-CANCER POLYKETIDE COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133535-A1 | ANTI-CANCER POLYKETIDE COMPOUNDS | SRPK3, HNRNPK, SRPK1 | SF3B3 192/4885HMGCR 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.